Trials / Completed
CompletedNCT04386148
Impact of Obsidian ® ASG on Anastomotic Healing
Impact of Obsidian® ASG Autologous Platelet-rich Fibrin Matrix on Anastomotic Healing in Colorectal Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- Kepler University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise morbidity and mortality. The literature identifies the leak rate for colorectal operations as 3-39%.
Detailed description
Introduction: The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise morbidity and mortality. The literature identifies the leak rate for colorectal operations as 3-39%. Methods: This is a prospective, multi-centre descriptive study commencing in June 2018. As part of the elective laparoscopic colorectal surgery, an autologous fibrin matrix was used as part of anastomotic technique in conjunction with activated thrombocytes (Obsidian ASG®). During anastomosis, this matrix was applied after resection onto the colorectal tissue surfaces with the aim of triggering tissue regeneration and improved wound healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Obsidian ASG® | As part of the elective laparoscopic colorectal surgery, an autologous fibrin matrix was used as part of anastomotic technique in conjunction with activated thrombocytes (Obsidian ASG®). During anastomosis, this matrix was applied after resection onto the colorectal tissue surfaces with the aim of triggering tissue regeneration and improved wound healing. |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2021-03-31
- Completion
- 2021-12-31
- First posted
- 2020-05-13
- Last updated
- 2023-10-05
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04386148. Inclusion in this directory is not an endorsement.